A phase III study of ibrutinib in combination with bendamustine and rituximab (BR) in elderly patients with newly diagnosed mantle cell lymphoma (MCL).
暂无分享,去创建一个
L. Gordon | M. Dreyling | O. Hermine | A. Goy | S. Rule | S. Zhuang | Michael Wang | A. Rizo